Biofourmis, a Singapore digital health startup, said it raised $35 million from investors and will move its headquarters to Boston.

“We would like to be closer to our customers, expand our commercial operations in the U.S., and also attract high quality talent,” founder and CEO Kuldeep Singh Rajput said in an email. “Boston is the right place to do so, with the right ecosystem for a digital therapeutics company.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy